II
ARQT icon

Inspire Investing’s Arcutis Biotherapeutics ARQT Stock Holding History

Inspire Investing’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Buy
26,019
+4,072
+19% +$94.9K 0.03% 644
2026
Q1 		$517K Buy
21,947
+6,111
+39% +$156K 0.03% 585
2025
Q4 		$460K Sell
15,836
-8,840
-36% -$226K 0.04% 730
2025
Q3 		$465K Sell
24,676
-4,096
-14% -$64.6K 0.05% 329
2025
Q2 		$403K Buy
28,772
+7,202
+33% +$101K 0.04% 324
2025
Q1 		$337K Sell
21,570
-7,353
-25% -$104K 0.04% 712
2024
Q4 		$403K Sell
28,923
-15,421
-35% -$169K 0.05% 425
2024
Q3 		$412K Buy
+44,344
New +$438K 0.04% 563

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Inspire Investing's ARQT Position: Q2 2026 in Review

Inspire Investing increased its Arcutis Biotherapeutics (ARQT) stake by 19% in Q2 2026, buying an estimated $94.9K and bringing the position to 26,019 shares worth $682K. The position accounts for 0.03% of the portfolio, ranked #644.

Inspire Investing first reported a position in ARQT in Q3 2024 and has held it in 8 quarters since. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Inspire Investing held 26,019 shares of Arcutis Biotherapeutics worth $682K as of Q2 2026.
  • Inspire Investing bought 4,072 Arcutis Biotherapeutics shares in Q2 2026, an estimated $94.9K.
  • Arcutis Biotherapeutics made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #644 holding.
  • Inspire Investing first reported a position in Arcutis Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.